{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:12:26Z","timestamp":1778685146444,"version":"3.51.4"},"reference-count":37,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"unspecified","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["NRRP M6C2 \u2013 PNRR-MR1-2022-12375873"],"award-info":[{"award-number":["NRRP M6C2 \u2013 PNRR-MR1-2022-12375873"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,4,23]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Haploinsufficiency of A20 (HA20) is a monogenic disease caused by heterozygous\n                      <jats:italic>TNFAIP3<\/jats:italic>\n                      variants. Despite the marked clinical variability, no genotype\u2013phenotype correlation or validated laboratory biomarkers have been identified so far. Neurobehavioural abnormalities have been reported in murine models, but their prevalence in humans remains unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe a cohort of patients with HA20 from two centres, evaluating age-related clinical variability; to assess the prevalence of neuropsychiatric symptoms; to explore the inflammatory profile of the patients, including interferon (IFN)-\u03b3-inducible chemokines (CXCL9\/10) and type 1 IFN signature (IS), as well as the therapies administered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical and laboratory data of 17 subjects from six families heterozygous for\n                      <jats:italic>TNFAIP3<\/jats:italic>\n                      variants (American College of Medical Genetics and Genomics class 4\u20135) were retrospectively collected. Disease activity, treatments, CXCL9\/10 and IS levels were collected. Continuous variables were expressed as medians (IQR). Age at onset was compared using the Kruskal-Wallis test, and groups were compared through the Wilcoxon test or Fisher\u2019s exact test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical manifestations included oral aphthosis (88%), recurrent fever (53%), gastrointestinal inflammation (53%), autoimmunity (47%), genital ulcers (47%), neuropsychiatric symptoms (41%), arthritis\/tenosynovitis (18%) and skin inflammation (12%). Disease onset before 5 years of age was associated with a higher prevalence of neuropsychiatric symptoms during lifetime (p=0.004), whereas arthritis was more common in patients with later onset. The median age at onset differed significantly according to the type of clinical manifestation (p&lt;0.001). Higher IS levels were found in patients with active disease (p&lt;0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HA20 shows marked clinical heterogeneity both between and within families. Clinical manifestations appear age-related and early disease onset was associated with increased neuropsychiatric involvement lifetime. Finally, type 1 IS may represent a potential biomarker of disease activity in HA20.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2026-006763","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:26:38Z","timestamp":1778682398000},"page":"e006763","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-3389","authenticated-orcid":false,"given":"Laura","family":"De Nardi","sequence":"first","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"},{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Federici","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"De Martino","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Celani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Girardelli","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Matteo","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Caiello","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Passarelli","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Perrone","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusi","family":"Prencipe","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tesser","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Pin","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Pastore","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bramuzzo","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Tommasini","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy"},{"name":"University of Trieste, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Insalaco","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, ERN-RITA Center, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2026051307253924000_12.2.e006763.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.10.005"},{"key":"2026051307253924000_12.2.e006763.2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-\u03baB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front Immunol"},{"key":"2026051307253924000_12.2.e006763.3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.574992"},{"key":"2026051307253924000_12.2.e006763.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.12.007"},{"key":"2026051307253924000_12.2.e006763.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.031"},{"key":"2026051307253924000_12.2.e006763.6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Vande Walle","year":"2014","journal-title":"Nature New Biol"},{"key":"2026051307253924000_12.2.e006763.7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3459"},{"key":"2026051307253924000_12.2.e006763.8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.804401","article-title":"Identification of a novel mutation in TNFAIP3 in a family with poly-autoimmunity","volume":"13","author":"Rossi","year":"2022","journal-title":"Front Immunol"},{"key":"2026051307253924000_12.2.e006763.9","doi-asserted-by":"crossref","first-page":"103722","DOI":"10.1016\/j.autrev.2024.103722","article-title":"A20 haploinsufficiency diagnosis beyond systemic lupus erythematosus: A systematic review of the literature","volume":"24","author":"Philip","year":"2025","journal-title":"Autoimmun Rev"},{"key":"2026051307253924000_12.2.e006763.10","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000532"},{"key":"2026051307253924000_12.2.e006763.11","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-11-122","article-title":"A20 deficiency causes spontaneous neuroinflammation in mice","volume":"11","author":"Guedes","year":"2014","journal-title":"J Neuroinflammation"},{"key":"2026051307253924000_12.2.e006763.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2019.100018","article-title":"A20\/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus","volume":"2","author":"Daems","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"2026051307253924000_12.2.e006763.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"2026051307253924000_12.2.e006763.14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"2026051307253924000_12.2.e006763.15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/apa.14792","article-title":"Towards better diagnostic criteria for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome","volume":"108","author":"Renko","year":"2019","journal-title":"Acta Paediatr"},{"key":"2026051307253924000_12.2.e006763.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160690"},{"key":"2026051307253924000_12.2.e006763.17","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics9030113","article-title":"An easy and reliable strategy for making type I interferon signature analysis comparable among research centers","volume":"9","author":"Pin","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"2026051307253924000_12.2.e006763.18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty897"},{"key":"2026051307253924000_12.2.e006763.19","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026051307253924000_12.2.e006763.20","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/ckj\/sfac130","article-title":"Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis","volume":"15","author":"Zhang","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026051307253924000_12.2.e006763.21","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00288-6"},{"key":"2026051307253924000_12.2.e006763.22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212403"},{"key":"2026051307253924000_12.2.e006763.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02494.x"},{"key":"2026051307253924000_12.2.e006763.24","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2014.3085"},{"key":"2026051307253924000_12.2.e006763.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.10.039"},{"key":"2026051307253924000_12.2.e006763.26","doi-asserted-by":"publisher","DOI":"10.1038\/nri3707"},{"key":"2026051307253924000_12.2.e006763.27","doi-asserted-by":"publisher","DOI":"10.1038\/nri3313"},{"key":"2026051307253924000_12.2.e006763.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.07.017"},{"key":"2026051307253924000_12.2.e006763.29","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-024-01681-1","article-title":"The complexity of being A20: from biological functions to genetic associations","volume":"44","author":"Karri","year":"2024","journal-title":"J Clin Immunol"},{"key":"2026051307253924000_12.2.e006763.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04376-5","article-title":"A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation","volume":"9","author":"Voet","year":"2018","journal-title":"Nat Commun"},{"key":"2026051307253924000_12.2.e006763.31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10875-019-00695-4","article-title":"A de novo frameshift mutation in TNFAIP3 impairs A20 deubiquitination function to cause neuropsychiatric systemic lupus erythematosus","volume":"39","author":"Duan","year":"2019","journal-title":"J Clin Immunol"},{"key":"2026051307253924000_12.2.e006763.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.05.026"},{"key":"2026051307253924000_12.2.e006763.33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819"},{"key":"2026051307253924000_12.2.e006763.34","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsx046"},{"key":"2026051307253924000_12.2.e006763.35","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03312-x","article-title":"Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening","volume":"26","author":"Milatz","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2026051307253924000_12.2.e006763.36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/1346-8138.15034","article-title":"Coinheritance of generalized pustular psoriasis and familial Beh\u00e7et-like autoinflammatory syndrome with variants in IL36RN and TNFAIP3 in the heterozygous state","volume":"46","author":"Liang","year":"2019","journal-title":"J Dermatol"},{"key":"2026051307253924000_12.2.e006763.37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1548042","article-title":"Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey","volume":"16","author":"Shiraki","year":"2025","journal-title":"Front Immunol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2026-006763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:26:41Z","timestamp":1778682401000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2026-006763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/rmdopen-2026-006763"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2026-006763","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}